As a consequence, a significant number of patients with MYH9‐RD are initially misdiagnosed as immune thrombocytopenic purpura (ITP), and thus subjected to ineffective and potentially harmful treatments, or classified as inherited platelet disorder of unknown origin. This evidence concerns the gene MYH9 and blood platelet disease.